RUNX2 and melanoma: Boregowda et al. showed that RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion by affecting the expression of focal adhesion kinase [13]; Cao et al. reported that RUNX2 was associated with EMT by regulating galectin-3 expression in hepatocellular carcinoma [14].